Mylan Laboratories

Mylan is a global pharmaceutical company with market leading positions in generic pharmaceuticals, transdermal technology and unit dose packaged products. We focus on providing an extensive line of affordable, high quality prescription drugs in traditional and innovative dosage forms, and we enjoy a well-deserved reputation for scientific expertise in creating difficult-to-formulate and high-barrier-to-entry generic products. Mylan operates three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc. (all wholly-owned), and has a 71.5% controlling interest in Matrix Laboratories Limited (71.5% owned). Mylan Pharmaceuticals Inc., with locations in Morgantown, W.Va., Caguas, Puerto Rico, and Greensboro, N.C., is a world leader in the research, development, production and marketing of generic pharmaceuticals. Mylan Technologies Inc., located in St. Albans and Swanton, Vt., is a leader in transdermal drug delivery technology and is the largest producer of generic and branded transdermal patches for the U.S. market. UDL Laboratories Inc., with locations in Rockford, Ill., and Sugar Land, Texas, is the top U.S.-supplier of unit dose pharmaceuticals to hospitals and other institutions. Mylan also owns a controlling interest in India-based Matrix Laboratories Limited, which provides Mylan with a platform for global expansion and growth. Matrix is the second largest supplier of active pharmaceutical ingredient (API) sourcing and provides expanded marketing capabilities through Docpharma, a Matrix subsidiary that is a primary marketer of branded generics in Europe. Matrix is a public limited company listed on the Bombay Stock Exchange and the National Stock Exchange of India and currently owns, in whole or in part, 12 other facilities and business units located in India, China and South Africa.

Contact Details: 1500 Corporate Drive Suite 400 Canonsburg PA 15317 United States of America Tel: 724-514-1800 Fax: Email: investor_relations@mylan.com WWW: www.mylan.com/

Loading...

BioNews Results for Mylan Laboratories:
Mylan Laboratories Inc - SWOT Analysis - New Research Report on Companies and Markets	PR inside:  Jul 2 2008 11:01PM Matching: mylan laboratories
Matrix Labs consolidated net loss at Rs 457 crore	PharmaBiz:  Jul 2 2008 8:37AM Matching: mylan laboratories
Barr, Mylan Receive Favorable Ruling in Mirapex Challenge	FDA News:  Jun 29 2008 7:18AM Matching: mylan laboratories
BMW Method healthy?	Motley Fool Discussion Boards:  Jun 23 2008 9:47PM Matching: mylan laboratories
New Report Studying Japan's Pharmaceutical Pricing and Reimbursement Procedures	Pharma Live:  Jun 19 2008 9:49PM Matching: mylan laboratories
Promote your company here: BioNewsCast - Press Release Distribution	→View more Mylan Laboratories news.

Mylan Laboratories (MYL) Financial information Links from Barchart
MYL Quote from from Barchart.com
MYL Chart from from Barchart.com
MYL Profile from from Barchart.com
MYL Opinion from from Barchart.com
→View more Mylan Laboratories finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1193 times since April 2007, the link to the organisation's website has been followed 125 times

Recent Search Terms used to find this page: mylan labs uk | Mylan uk | Mylan Laboratories Inc South Africa | where is mylan located | where is mylan located | mylan laboratories uk telephone | mylan pharmaceuticals email tel | mylan india contact no | Abbott Mylan | Mylan uk | .

Search for more companies in Canonsburg

Search for more companies in PA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Mylan Laboratories